Zentalis Pharmaceuticals, Inc.
News
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Shares Sold by Zurcher Kantonalbank Zurich Cantonalbank
Ticker Report Zurcher Kantonalbank Zurich Cantonalbank lessened its holdings in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL - Free Report) by 50.0% during the 2nd quarter, HoldingsChannel.com reports. The firm...\n more…
Zentalis Pharmaceuticals to Present Preclinical Azenosertib Data at ESMO 2024
Globe Newswire Azenosertib shows synergistic anti-tumor effects in combination with topoisomerase I (TOP1) inhibitor-based antibody drug conjugatesSAN DIEGO, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Zentalis...\n more…
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire SAN DIEGO, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small...\n more…
14,152 Shares in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Purchased by SG Americas Securities LLC
Ticker Report SG Americas Securities LLC purchased a new stake in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The...\n more…
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Receives Average Rating of "Hold" from Analysts
Ticker Report Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL - Get Free Report) has earned a consensus recommendation of "Hold" from the ten brokerages that are covering the firm, MarketBeat reports. Seven equities...\n more…
Newman Ferrara LLP Announces Corporate Governance Investigation of Zentalis Pharmaceuticals, Inc. ZNTL
Business Wire Newman Ferrara LLP announced today that the firm is conducting an investigation on behalf of shareholders of Zentalis Pharmaceuticals, Inc. (Zentalis or the Company) (NASDAQ:ZNTL) into potential...\n more…